CellSeed Inc.

As of June 30, 2026, CellSeed Inc. carries a market capitalization of 8.49B, placing it among publicly traded companies globally. Its enterprise value stands at 6.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CellSeed Inc.'s next confirmed earnings release is scheduled for November 13, 2026.

As of June 30, 2026, CellSeed Inc. has 39.32M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, CellSeed Inc. maintains a current ratio of 10.41, meaning it holds 10.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, CellSeed Inc.'s stock has declined approximately 57.14% over the past 52 weeks. The 50-day moving average sits at 221.42, while the 200-day moving average is 259.63.

As of June 30, 2026, CellSeed Inc. holds 1.79B in cash and equivalents against 116.87M in total debt, resulting in a net debt position of -1.68B. Total book value stands at 1.77B, with working capital of 1.76B providing operational flexibility.